ELIQUENT Life Sciences Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
237
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
6
ELIQUENT Life Sciences General Information
Description
Provider of compliance and regulatory affairs consulting services intended to serve pharmaceutical, biologics, medical device and diagnostics manufacturers. The company offers reliable systems design, strategy, implementation, health authority enforcement action response as well as remediation services, thereby ensuring safe and reliable access to life-saving healthcare products.
Contact Information
Website
www.validant.comCorporate Office
- 150 Sutter Street
- Suite 75
- San Francisco, CA 94104
- United States
Corporate Office
- 150 Sutter Street
- Suite 75
- San Francisco, CA 94104
- United States
ELIQUENT Life Sciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ELIQUENT Life Sciences Comparisons
Industry
Financing
Details
ELIQUENT Life Sciences Competitors (25)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Greenleaf Health | Private Equity-Backed | Washington, DC | 00 | 000000000000 | ||
ProPharma Group | Private Equity-Backed | Raleigh, NC | 0000 | 000.00 | 000000000 - | 000.00 |
RQM+ | Private Equity-Backed | Monroeville, PA | 000 | 00000 | 000000000 | 00000 |
4C Pharma Solutions | Corporation | Piscataway, NJ | 000 | |||
Qserve Group | Corporation | 00 |
ELIQUENT Life Sciences Executive Team (13)
Name | Title | Board Seat |
---|---|---|
Tim Dietlin | Chief Executive Officer | |
Brian Burns | President | |
Steve Purtell | Chief Financial Officer | |
Barbara Clendenen | Chief Business Development Officer | |
Martyn Edney | Chief Human Resources Officer |
ELIQUENT Life Sciences Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
0000000 00000000 | GHO Capital | Board Member | 000 0000 |
0000000 000000 | GHO Capital | Board Member | 000 0000 |
000000 00000000 | GHO Capital | Board Member | 000 0000 |
ELIQUENT Life Sciences Signals
ELIQUENT Life Sciences Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ELIQUENT Life Sciences Investments (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
RApport Global Strategic Services | 18-Jan-2024 | 0000000000 | Consulting Services (B2B) | 000 00000 | |
Clinical Outcome Solutions | 20-May-2021 | 0000000000 | Consulting Services (B2B) | 0000000 0 | |
Greenleaf Health | 19-Apr-2021 | 0000000000 | Consulting Services (B2B) | 0000000 0 | |
Oriel Stat A Matrix | 31-Dec-2020 | 0000000000 | Consulting Services (B2B) | 00000 000 | |
IDEC (Japan) | 24-Nov-2020 | Buyout/LBO | Practice Management (Healthcare) | 00000 000 |
ELIQUENT Life Sciences Subsidiaries (6)
Company Name | Industry | Location | Founded |
---|---|---|---|
DataRevive | Consulting Services (B2B) | Rockville, MD | 2016 |
Clinical Outcome Solutions | Consulting Services (B2B) | Tucson, AZ | 0000 |
Greenleaf Health | Consulting Services (B2B) | Washington, DC | 0000 |
IDEC (Japan) | Practice Management (Healthcare) | Tokyo, Japan | 0000 |
RApport Global Strategic Services | Consulting Services (B2B) | Camberley, United Kingdom | 0000 |
ELIQUENT Life Sciences FAQs
-
When was ELIQUENT Life Sciences founded?
ELIQUENT Life Sciences was founded in 2005.
-
Who is the founder of ELIQUENT Life Sciences?
Brian Healy is the founder of ELIQUENT Life Sciences.
-
Who is the CEO of ELIQUENT Life Sciences?
Tim Dietlin is the CEO of ELIQUENT Life Sciences.
-
Where is ELIQUENT Life Sciences headquartered?
ELIQUENT Life Sciences is headquartered in San Francisco, CA.
-
What is the size of ELIQUENT Life Sciences?
ELIQUENT Life Sciences has 237 total employees.
-
What industry is ELIQUENT Life Sciences in?
ELIQUENT Life Sciences’s primary industry is Practice Management (Healthcare).
-
Is ELIQUENT Life Sciences a private or public company?
ELIQUENT Life Sciences is a Private company.
-
What is ELIQUENT Life Sciences’s current revenue?
The current revenue for ELIQUENT Life Sciences is 000000.
-
How much funding has ELIQUENT Life Sciences raised over time?
ELIQUENT Life Sciences has raised $2.28M.
-
Who are ELIQUENT Life Sciences’s investors?
Goldman Sachs Asset Management, Los Angeles County Employees' Retirement Association, and GHO Capital have invested in ELIQUENT Life Sciences.
-
Who are ELIQUENT Life Sciences’s competitors?
Greenleaf Health, ProPharma Group, RQM+, 4C Pharma Solutions, and Qserve Group are some of the 25 competitors of ELIQUENT Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »